[1. Slobodin G, Rosner I, Rimar D, Boulman N, Rozenbaum M, Odeh M. Ankylosing spondylitis: field in progress. Isr Med Assoc J. 2012;14(12):763-7.]Search in Google Scholar
[2. Thomas GP, Brown MA. Genetics and genomics of ankylosing spondylitis. Immunol Rev. 2010;233(1):162-80. DOI: 10.1111/j.0105-2896.2009.00852.x10.1111/j.0105-2896.2009.00852.x20192999]Search in Google Scholar
[3. Snelgrove T, Lim S, Greenwood C, Peddle L, Hamilton S, Inman R, et al. Association of toll-like receptor 4 variants and ankylosing spondylitis: a case-control study. J Rheumatol. 2007;34(2):368-70.]Search in Google Scholar
[4. De Vlam K. Soluble and tissue biomarkers in ankylosing spondylitis. Best Pract Res Clin Rheumatol. 2010;24(5):671-82. DOI: 10.1016/j.berh.2010.05.00910.1016/j.berh.2010.05.00921035087]Search in Google Scholar
[5. Wang QH, Zhang SZ, Xue J, Wu HX. Serum metalloproteinase-3 levels in assessing efficacy of Etanercept in patients with ankylosing spondylitis. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010;39(4):409-14 (abstract).]Search in Google Scholar
[6. Maksymowych WP, Landewé R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole AR, Wang N, van der Heijde D. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.]Search in Google Scholar
[Arthritis Rheum. 2007;56(6):1846-53 DOI: 10.1002/ art.22589]Search in Google Scholar
[7. Gouveia EB, Elmann D, Morales MS. Ankylosing spondylitis and uveitis: overview. Rev Bras Reumatol. 2012;52(5):742-56.]Search in Google Scholar
[8. El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011;22(6):554-60. DOI: 10.1016/j.ejim.2011.06.00610.1016/j.ejim.2011.06.00622075279]Search in Google Scholar
[9. Robertson LP, Davis MJ. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology (Oxford). 2004;43(12):1565-8. DOI: 10.1093/rheumatology/ keh386]Search in Google Scholar
[10. Chang JH, McCluskey PJ, Wakefield D. 2009. Acute Anterior Uveitis and HLA-B27: What’s New? in Uveitis and Immunological Disorders Progress III, U Pleyer, JV Forrester eds. Springer-Verlag, Berlin Heidelberg. p. 9-18. DOI: 10.1007/978-3-540-69459-5_210.1007/978-3-540-69459-5_2]Search in Google Scholar
[11. Li H, Yoneda M, Takeyama M, Sugita I, Tsunekawa H, Yamada H, et al. Effect of infliximab on tumor necrosis factor-alpha-induced alterations in retinal microvascular endothelial cells and retinal pigment epithelial cells. J Ocul Pharmacol Ther. 2010;26(6):549-56. DOI: 10.1089/jop.2010.007910.1089/jop.2010.007921054185]Search in Google Scholar
[12. Di Girolamo N, Verma MJ, McCluskey PJ, Lloyd A, Wakefield D. Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis. Curr Eye Res. 1996;15(10):1060-8.10.3109/027136896090176568921246]Search in Google Scholar
[DOI: 10.3109/0271368960901765610.3109/02713689609017656]Search in Google Scholar
[13. Cuello C, Wakefield D, Di Girolamo N. Neutrophil accumulation correlates with type IV collagenase/gelatinase activity in endotoxin induced uveitis. Br J Ophtalmol. 2002;86(3):290-5. DOI: 10.1136/bjo.86.3.29010.1136/bjo.86.3.290177105911864886]Search in Google Scholar
[14. Yamada H, Yoneda M, Inaguma S, Watanabe D, Banno S, Yoshikawa K, et al. Infliximab counteracts tumor necrosis factor-α-enhanced induction of matrix metalloproteinases that degrade claudin and occludin in non-pigmented ciliary epithelium. Biochem Pharmacol. 2013;85(12):1770-82. DOI: 10.1016/j.bcp.2013.04.00610.1016/j.bcp.2013.04.00623603294]Search in Google Scholar
[15. Martin TM, Bye L, Modi N, Stanford MR, Vaughan R, Smith JR, et al. Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort. Mol Vis. 2009;15:208-12.]Search in Google Scholar
[16. Fossum S, Mallett S, Barclay AN. The MRC OX-47 antigen is a member of the immunoglobulin superfamily with an unusual transmembrane sequence. Eur J Immunol. 1991;21(3):671-9. DOI: 10.1002/eji.183021032010.1002/eji.18302103202009910]Search in Google Scholar
[17. Koch C, Staffler G, Hüttinger R, Hilgert I, Prager E, Cerný J, et al. T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density.]Search in Google Scholar
[Int Immunol. 1999;11(5):777-86. DOI: 10.1093/intimm/]Search in Google Scholar
[11.5.777]Search in Google Scholar
[18. Määttä M, Tervahartiala T, Kaarniranta K, Tang Y, Yan L, Tuukkanen J, et al. Immunolocalization of EMMPRIN (CD147) in the human eye and detection of soluble form of EMMPRIN in ocular fluids. Curr Eye Res. 2006;31(11):917-24. DOI: 10.1080/0271368060093229010.1080/02713680600932290]Search in Google Scholar
[19. Biswas C. Tumor cell stimulation of collagenase production by fibroblasts. Biochem Biophys Res Commun. 1982;109(3):1026-34. DOI: 10.1016/0006-291X(82)92042-310.1016/0006-291X(82)92042-3]Search in Google Scholar
[20. Philp NJ, Ochrietor JD, Rudoy C, Muramatsu T, Linser PJ. Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse. Invest Ophthalmol Vis Sci. 2003;44(3):1305-11. DOI: 10.1167/iovs.02-055210.1167/iovs.02-055212601063]Search in Google Scholar
[21. Gabison EE, Mourah S, Steinfels E, Yan L, Hoang-Xuan T, Watsky MA, et al. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.]Search in Google Scholar
[Am J Pathol. 2005;166(1):209-19. DOI: 10.1016/ S0002-9440(10)62245-6]Search in Google Scholar
[22. Iacono KT, Brown AL, Greene MI, Saouaf SJ. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol. 2007;83(3):283-95.10.1016/j.yexmp.2007.08.014221173917945211]Search in Google Scholar
[DOI: 10.1016/j.yexmp.2007.08.01410.1016/j.yexmp.2007.08.014]Search in Google Scholar
[23. Taylor PM, Woodfield RJ, Hodgkin MN, Pettitt TR, Martin A, Kerr DJ, et al. Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathway.]Search in Google Scholar
[Oncogene. 2002;21(37):5765-72. DOI: 10.1038/ sj.onc.120570210.1038/sj.onc.120570212173047]Search in Google Scholar
[24. Sidhu SS, Mengistab AT, Tauscher AN, LaVail J, Basbaum C. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene. 2004;23(4):956-63. DOI: 10.1038/sj.onc.120707010.1038/sj.onc.120707014749763]Search in Google Scholar
[25. Egawa N, Koshikawa N, Tomari T, Nabeshima K, Isobe T, Seiki M. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells. J Biol Chem. 2006;281(49):37576-85. DOI: 10.1074/jbc.10.1074/jbc]Search in Google Scholar
[M606993200]Search in Google Scholar
[26. Onodera J, Onodera S, Kondo E, Betsuyaku T, Yasuda K. A soluble factor (EMMPRIN) in exudate influences knee motion after total arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2009;17(3):298-304. DOI: 10.1007/s00167-008-0688-610.1007/s00167-008-0688-619089410]Search in Google Scholar
[27. Yanaba K, Asano Y, Tada Y, Sugaya M, Kadono T, Hamaguchi Y, et al. Increased serum soluble CD147 levels in patients with systemic sclerosis: association with scleroderma renal crisis. Clin Rheumatol. 2012;31(5):835-9. DOI: 10.1007/s10067-012-1949-910.1007/s10067-012-1949-922298186]Search in Google Scholar
[28. Wang M, Huang ZX, Pan YF, Zhang FC, Zheng BR, Deng WM, et al. Expressions of CD147 in peripheral monocytes and T lymphocytes of patients with ankylosing spondylitis. Zhonghua Yi Xue Za Zhi. 2010;90(41):2902-6 (abstract).]Search in Google Scholar
[29. Dhir V, Srivastava R, Aggarwal A. Circulating Levels of Soluble Receptor Activator of NF- κ B Ligand and Matrix Metalloproteinase 3 (and Their Antagonists) in Asian Indian Patients with Ankylosing Spondylitis.]Search in Google Scholar
[Int J Rheumatol. 2013;2013:814350. DOI: 10.1155/2013/81435010.1155/2013/814350]Search in Google Scholar
[30. Veidal SS, Larsen DV, Chen X, Sun S, Zheng Q, Bay-Jensen AC, et al. MMP mediated type V collagen degradation (C5M) is elevated in ankylosing spondylitis.]Search in Google Scholar
[Clin Biochem. 2012;45(7-8):541-6 DOI: 10.1016/j. clinbiochem.2012.02.007]Search in Google Scholar
[31. Mattey DL, Packham JC, Nixon NB, Coates L, Creamer P, Hailwood S, et al. Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis. Arthritis Res Ther. 2012;14(3):R127 DOI: 10.1186/ar385710.1186/ar3857]Search in Google Scholar
[32. Moll JM, Wright V. New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis. 1973;32(4):354-63. DOI: 10.1136/ard.32.4.35410.1136/ard.32.4.354]Search in Google Scholar
[33. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis.]Search in Google Scholar
[A proposal for modification of the New York criteria.]Search in Google Scholar
[Arthritis Rheum. 1984;27(4):361-8. DOI: 10.1002/ art.178027040110.1002/art.1780270401]Search in Google Scholar
[34. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286-91.]Search in Google Scholar
[35. Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, et al. Assessment of SpondyloArthritis international Society. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68(1):18-24.10.1136/ard.2008.094870]Search in Google Scholar
[DOI: 10.1136/ard.2008.09487010.1136/ard.2008.094870]Search in Google Scholar
[36. Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281-5.]Search in Google Scholar
[37. Matache C, Stefanescu M, Dragomir C, Tanaseanu S, Onu A, Ofiteru A, et al. Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J Autoimmun. 2003; 20(4): 323-31. DOI: 10.1016/S0896-8411(03)00037-410.1016/S0896-8411(03)00037-4]Search in Google Scholar
[38. Chen CH, Lin KC, Chen HA, Liao HT, Liang TH, Wang HP, et al. Association of acute anterior uveitis with disease activity, functional ability and physical mobility in patients with ankylosing spondylitis: a cross-sectional study of Chinese patients in Taiwan. Clin Rheumatol. 2007;26(6):953-7. DOI: 10.1007/s10067-006-0403-210.1007/s10067-006-0403-217021671]Search in Google Scholar
[39. Berg IJ, Semb AG, van der Heijde D, Kvien TK, Hisdal J, Olsen IC, et al. Uveitis is associated to hypertension and atherosclerosis in patients with ankylosing spondylitis: a cross-sectional study. Semin Arthritis Rheum.]Search in Google Scholar
[2014. pii: S0049-0172(14)00111-5. doi: 10.1016/j. semarthrit.2014.05.017. DOI: 10.1016/j.semarthrit.]Search in Google Scholar
[2014.05.017]Search in Google Scholar
[40. Cordiali-Fei P, Trento E, D’Agosto G, Bordignon V, Mussi A, Ardigó M, et al. Effective therapy with anti- TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions.]Search in Google Scholar
[Ann N Y Acad Sci. 2007;1110:578-89. DOI: 10.1196/ annals.1423.062]Search in Google Scholar
[41. Chen CH, Lin KC, Yu DT, Yang C, Huang F, Chen HA, et al. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology (Oxford). 2006;45(4):414-20. DOI: 10.1093/rheumatology/kei20810.1093/rheumatology/kei20816287916]Search in Google Scholar
[42. Yurchenko V, Constant S, Eisenmesser E, Bukrinsky M. Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics. Clin Exp Immunol. 2010;160(3):305-17. DOI: 10.1111/j.1365-2249.2010.04115.x10.1111/j.1365-2249.2010.04115.x288310020345978]Search in Google Scholar
[43. Pistol G, Matache C, Calugaru A, Stavaru C, Tanaseanu S, Ionescu R, et al. Roles of CD147 on T lymphocytes activation and MMP-9 secretion in systemic lupus erythematosus.]Search in Google Scholar
[J Cell Mol Med. 2007;11(2):339-48. DOI: 10.1111/j.1582-4934.2007.00022.x10.1111/j.1582-4934.2007.00022.x382283217488482]Search in Google Scholar
[44. Han YP, Tuan TL, Wu H, Hughes M, Garner WL.]Search in Google Scholar
[TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci. 2001;114(Pt 1):131-139.10.1242/jcs.114.1.131243508911112697]Search in Google Scholar
[45. Bellayr IH, Mu X, Li Y. Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments. Future Med Chem. 2009;1(6):1095-111. DOI: 10.4155/fmc.09.8310.4155/fmc.09.83279413820161478]Search in Google Scholar
[46. Kaneider NC, Mosheimer B, Günther A, Feistritzer C, Wiedermann CJ. Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9. Thromb J. 2010;8(1):2-7.10.1186/1477-9560-8-2283762020181055]Search in Google Scholar
[DOI: 10.1186/1477-9560-8-210.1186/1477-9560-8-2]Search in Google Scholar
[47. Tarhini AA, Lin Y, Yeku O, LaFramboise WA, Ashraf M, Sander C, et al. A four-marker signature of TNFRII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma. J Transl Med. 2014,12:19. DOI: 10.1186/1479-5876-12-1910.1186/1479-5876-12-19390938424457057]Search in Google Scholar
[48. Gehlen M, Regis KC, Skare TL. Demographic, clinical, laboratory and treatment characteristics of spondyloarthritis patients with and without acute anterior uveitis.]Search in Google Scholar
[Sao Paolo Med J. 2012;130(3):141-4. DOI: 10.1590/ S1516-31802012000300002 10.1590/S1516-31802012000300002]Search in Google Scholar